665 related articles for article (PubMed ID: 33970745)
1. Impact of anti-cancer therapy on disease severity and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
Lin Z; Chen J; Han S
Expert Rev Anticancer Ther; 2021 Sep; 21(9):1055-1066. PubMed ID: 33970745
[No Abstract] [Full Text] [Related]
2. Immunotherapy or other anti-cancer treatments and risk of exacerbation and mortality in cancer patients with COVID-19: a systematic review and meta-analysis.
Wang B; Huang Y
Oncoimmunology; 2020 Sep; 9(1):1824646. PubMed ID: 33294299
[TBL] [Abstract][Full Text] [Related]
3. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data.
Park R; Lee SA; Kim SY; de Melo AC; Kasi A
Acta Oncol; 2021 Jan; 60(1):13-19. PubMed ID: 33131376
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis.
Sheng Z; Zhang L; Liu X; Yuan L; Li F; Dai D; Wu S; Yang J
Medicine (Baltimore); 2020 Jul; 99(31):e21487. PubMed ID: 32756178
[TBL] [Abstract][Full Text] [Related]
5. Impact of Coinfection With SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis.
Guan Z; Chen C; Li Y; Yan D; Zhang X; Jiang D; Yang S; Li L
Front Public Health; 2021; 9():773130. PubMed ID: 34957025
[No Abstract] [Full Text] [Related]
6. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
[TBL] [Abstract][Full Text] [Related]
7. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants.
Wu Q; Luo S; Xie X
BMC Cancer; 2022 Mar; 22(1):241. PubMed ID: 35246063
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
9. Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis.
Chu Y; Yang J; Shi J; Zhang P; Wang X
Eur J Med Res; 2020 Dec; 25(1):64. PubMed ID: 33267871
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for mortality of coronavirus disease 2019 (COVID-19) patients during the early outbreak of COVID-19: a systematic review and meta-analysis.
Wu Y; Li H; Zhang Z; Liang W; Zhang T; Tong Z; Guo X; Qi X
Ann Palliat Med; 2021 May; 10(5):5069-5083. PubMed ID: 33894729
[TBL] [Abstract][Full Text] [Related]
11. Coagulopathy in patients with COVID-19: a systematic review and meta-analysis.
Zhang X; Yang X; Jiao H; Liu X
Aging (Albany NY); 2020 Nov; 12(24):24535-24551. PubMed ID: 33229625
[TBL] [Abstract][Full Text] [Related]
12. Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis.
Liu Y; Pan Y; Yin Y; Chen W; Li X
Virol J; 2021 Jul; 18(1):157. PubMed ID: 34315474
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Integrated Traditional Chinese and Western Medicine for Treating COVID-19: A Systematic Review and Meta-Analysis of RCTs.
Yin B; Bi YM; Sun L; Huang JZ; Zhao J; Yao J; Li AX; Wang XZ; Fan GJ
Front Public Health; 2021; 9():622707. PubMed ID: 34307269
[No Abstract] [Full Text] [Related]
14. Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis.
Yang Y; Cai Z; Zhang J
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33480978
[TBL] [Abstract][Full Text] [Related]
15. Obesity and clinical severity in patients with COVID-19: a scoping review protocol.
Costa ML; Souza CAS; Silva ACC; Santos DFC; Nonato EF; Santana FB; Dos Santos Dias G; Barreto JT; Costa LS; Costa MCB; das Neves Ferreira T; Santana JS; Mendes-Netto RS; do Nascimento TVSB; Nunes MAP; de Souza MFC
Syst Rev; 2021 Feb; 10(1):51. PubMed ID: 33550984
[TBL] [Abstract][Full Text] [Related]
16. Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis.
Cai Z; Yang Y; Zhang J
BMC Public Health; 2021 Aug; 21(1):1505. PubMed ID: 34348687
[TBL] [Abstract][Full Text] [Related]
17. Intravenous vitamin C use and risk of severity and mortality in COVID-19: A systematic review and meta-analysis.
Ao G; Li J; Yuan Y; Wang Y; Nasr B; Bao M; Gao M; Qi X
Nutr Clin Pract; 2022 Apr; 37(2):274-281. PubMed ID: 35148440
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of mesenchymal stem cells for the treatment of patients infected with COVID-19: a systematic review and meta-analysis protocol.
Chen Y; Zhang Q; Peng W; Liu D; You Y; Liu X; Tang S; Zhang T
BMJ Open; 2020 Dec; 10(12):e042085. PubMed ID: 33371042
[TBL] [Abstract][Full Text] [Related]
19. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
Zinellu A; Mangoni AA
Front Immunol; 2021; 12():696085. PubMed ID: 34163491
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis.
Pranata R; Lim MA; Yonas E; Vania R; Lukito AA; Siswanto BB; Meyer M
Diabetes Metab; 2021 Mar; 47(2):101178. PubMed ID: 32738402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
